Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SEC14L2 |
| Upstream (Parents) |
|---|
| (<<) F11 → SEC14L2 |
| (<<) MOSC2 → SEC14L2 |
| Downstream (Children) |
|---|
| SEC14L2 → PROCR (>>) |
| SEC14L2 → DNMT3L (>>) |
| SEC14L2 → DSG1 (>>) |
| SEC14L2 → RUNDC3B (>>) |
| SEC14L2 → CYP7B1 (>>) |
| SEC14L2 → GCAT (>>) |
| SEC14L2 → SLC23A2 (>>) |
| SEC14L2 → PGA4///PGA3///PGA5 (>>) |
| SEC14L2 → ITPR2 (>>) |
| SEC14L2 → PRDM9 (>>) |
| SEC14L2 → FAHD2A (>>) |
| SEC14L2 → NSUN6 (>>) |
